Glen Eagle Advisors, LLC Lantheus Holdings, Inc. Transaction History
Glen Eagle Advisors, LLC
- $719 Billion
- Q3 2025
A detailed history of Glen Eagle Advisors, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 433 shares of LNTH stock, worth $22,953. This represents 0.0% of its overall portfolio holdings.
Number of Shares
433
Previous 433
-0.0%
Holding current value
$22,953
Previous $35.4 Million
37.34%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding LNTH
# of Institutions
478Shares Held
68.9MCall Options Held
522KPut Options Held
312K-
Black Rock Inc. New York, NY8.6MShares$456 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.95MShares$369 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X06.68MShares$354 Million0.17% of portfolio
-
Morgan Stanley New York, NY3.88MShares$206 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.48MShares$184 Million0.77% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $3.64B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...